4.0 Article

Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open-Label, Maximal-Use Systemic Exposure Study

Related references

Note: Only part of the references are listed.
Article Dermatology

Guidelines of care for the management of atopic dermatitis

Robert Sidbury et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)

Article Dermatology

Guidelines of care for the management of atopic dermatitis Section 2. Management and treatment of atopic dermatitis with topical therapies

Lawrence F. Eichenfield et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)

Article Biochemistry & Molecular Biology

Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center

Yvonne R. Freund et al.

FEBS LETTERS (2012)

Review Dermatology

Calcineurin Inhibitors in Pediatric Atopic Dermatitis A Review of Current Evidence

Manjunatha Kalavala et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)

Review Medicine, General & Internal

Mechanisms of disease: Atopic dermatitis

Thomas Bieber

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Dermatology

Adverse effects of topical glucocorticosteroids

UR Hengge et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)

Article Dermatology

The burden of atopic dermatitis: Impact on the patient, family, and society

CL Carroll et al.

PEDIATRIC DERMATOLOGY (2005)